Karamanos NK - Search Results

1

Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer.

Misra S, Ghatak S, Vyas A, O'Brien P, Markwald RR, Khetmalas M, Hascall VC, McCarthy JB, Karamanos NK, Tammi MI, Tammi RH, Prestwitch GD, Padhye S. Misra S, et al. Among authors: karamanos nk. Med Chem Res. 2014 Aug 1;23(8):3836-3851. doi: 10.1007/s00044-014-0958-4. Med Chem Res. 2014. PMID: 25013352 Free PMC article.

2

Regulatory roles of hyaluronan in health and disease.

Hascall V, Karamanos N. Hascall V, et al. FEBS J. 2011 May;278(9):1411. doi: 10.1111/j.1742-4658.2011.08068.x. Epub 2011 Mar 25. FEBS J. 2011. PMID: 21362135 Free article. No abstract available.

3

Hyaluronan-CD44 interactions as potential targets for cancer therapy.

Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, Ghatak S. Misra S, et al. Among authors: karamanos nk. FEBS J. 2011 May;278(9):1429-43. doi: 10.1111/j.1742-4658.2011.08071.x. Epub 2011 Mar 25. FEBS J. 2011. PMID: 21362138 Free PMC article. Review.

4

Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.

Kouvidi K, Berdiaki A, Nikitovic D, Katonis P, Afratis N, Hascall VC, Karamanos NK, Tzanakakis GN. Kouvidi K, et al. Among authors: karamanos nk. J Biol Chem. 2011 Nov 4;286(44):38509-38520. doi: 10.1074/jbc.M111.275875. Epub 2011 Sep 13. J Biol Chem. 2011. PMID: 21914806 Free PMC article.

5

Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.

Karousou E, Misra S, Ghatak S, Dobra K, Götte M, Vigetti D, Passi A, Karamanos NK, Skandalis SS. Karousou E, et al. Among authors: karamanos nk. Matrix Biol. 2017 May;59:3-22. doi: 10.1016/j.matbio.2016.10.001. Epub 2016 Oct 13. Matrix Biol. 2017. PMID: 27746219 Review.

6

Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.

Ghatak S, Hascall VC, Karamanos N, Markwald RR, Misra S. Ghatak S, et al. Front Oncol. 2022 Aug 2;12:906415. doi: 10.3389/fonc.2022.906415. eCollection 2022. Front Oncol. 2022. PMID: 35982950 Free PMC article.

7

Chemotherapy induces feedback up-regulation of CD44v6 in colorectal cancer initiating cells through β-catenin/MDR1 signaling to sustain chemoresistance.

Ghatak S, Hascall VC, Karamanos N, Markwald RR, Misra S. Ghatak S, et al. Front Oncol. 2022 Oct 18;12:906260. doi: 10.3389/fonc.2022.906260. eCollection 2022. Front Oncol. 2022. PMID: 36330477 Free PMC article.

8

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

Roussidis AE, Theocharis AD, Tzanakakis GN, Karamanos NK. Roussidis AE, et al. Among authors: karamanos nk. Curr Med Chem. 2007;14(7):735-43. doi: 10.2174/092986707780090963. Curr Med Chem. 2007. PMID: 17346159 Review.

9

Targeting epidermal growth factor receptor in solid tumors: critical evaluation of the biological importance of therapeutic monoclonal antibodies.

Gialeli Ch, Kletsas D, Mavroudis D, Kalofonos HP, Tzanakakis GN, Karamanos NK. Gialeli Ch, et al. Among authors: karamanos nk. Curr Med Chem. 2009;16(29):3797-804. doi: 10.2174/092986709789177984. Curr Med Chem. 2009. PMID: 19747140 Review.

10

Pathophysiology and pharmacological targeting of tumor-induced bone disease: current status and emerging therapeutic interventions.

Labropoulou VT, Theocharis AD, Symeonidis A, Skandalis SS, Karamanos NK, Kalofonos HP. Labropoulou VT, et al. Among authors: karamanos nk. Curr Med Chem. 2011;18(11):1584-98. doi: 10.2174/092986711795471275. Curr Med Chem. 2011. PMID: 21428887 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters